Physician profile
Bronson W Hamada
NPI 1447285028
$5,596.85
in general payments reported to CMS, 2019-2025
15 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $856 · 2020: $355 · 2021: $2,217 · 2022: $544 · 2023: $692 · 2024: $539 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,606 · Entertainment: $19.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,605.95 |
| Entertainment | $19.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $2,691.94 | 2019-2025 | Acuvue |
| Reichert, INC. | $1,247.81 | 2021 | |
| Bausch & Lomb Americas INC. | $641.04 | 2022-2025 | Infuse, Miebo |
| Alcon Vision LLC | $539.48 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.69 | 2021 | |
| Sun Pharmaceutical Industries INC. | $117.39 | 2024-2025 | |
| Johnson & Johnson Surgical Vision, INC. | $62.85 | 2020-2021 | |
| Optos, INC. | $59.76 | 2021-2025 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Oyster Point Pharma, INC. | $28.39 | 2022 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Rayner Intraocular Lenses Limited | $18.22 | 2025 | Omidria |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Sight Sciences, INC. | $11.67 | 2022 | |
| Abb Con-Cise Optical Group LLC | $11.00 | 2019 | |
| Maculogix, INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bronson Hamada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.